Schiff Hardin Counsels GBS, Inc. in $21.6M IPO

Schiff Hardin LLP counseled GBS, Inc.’s initial public offering of 1,270,589 units of securities at $17.00 per unit. GBS, Inc. is a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care, and the company intends to use the net proceeds from this offering for obtaining regulatory approvals, marketing and establishing a distribution network, in addition to working capital. The offering closed on December 28, 2020, resulting in gross proceeds to the Issuer of $21.6 million.